• Matthias P Lichy, Philip Aschoff, Christian Plathow, Alto Stemmer, Wilhelm Horger, Christian Mueller-Horvat, Gunter Steidle, Marius Horger, Jurgen Schafer, Susanne M Eschmann, Berthold Kiefer, Claus D Claussen, Christina Pfannenberg, and Heinz-Peter Schlemmer.
• Department of Diagnostic Radiology, Medical Solutions, Erlangen, Germany. matthias.lichy@med.uni-tuebingen.de
• Invest Radiol. 2007 Sep 1; 42 (9): 605-13.

ObjectiveTo evaluate the clinical potential of diffusion-weighted-imaging (DWI) with apparent diffusion coefficient (ADC)-mapping for tumor detection.Materials And MethodsA single-shot echo-planar-imaging DWI sequence with fat suppression and ability for navigator-based respiratory triggering was implemented. Nineteen patients (11 melanoma, 4 prostate cancer, 1 non-Hodgkin lymphoma, and 3 lung cancer) were examined by positron emission tomography (PET) with an integrated computed tomography scanner (PET-CT) and DWI. Images at b = 0, 400, and 1000 s/mm2 were acquired and ADC maps were generated. PET examinations were used as a reference for tumor detection. Four hundred twenty-four regions of interest were used for DWI and 73 for PET data evaluation.ResultsDWI and ADC maps were of diagnostic quality. Metastases with increased tracer uptake were clearly visualized at b = 1000 s/mm2 with the exception of mediastinal lymph node metastases in cases of lung cancer. ADC mapping did not improve detection rates.ConclusionsDWI is a feasible clinical technique, improving the assessment of metastatic spread in routine magnetic resonance imaging examinations.

20 keywords...

hide…